EP2384791
13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl- prostaglandin E1 for treating inflammatory bowel disease
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.3.2006EP published:
15.6.2016EP application number:
11170933.3
EPO information:
European Patent Register
Max expiry date:
21.3.2026
Title:
13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl- prostaglandin E1 for treating inflammatory bowel disease
Timeline
Today
22.3.2006EP application
15.6.2016EP Publication
Owner
Name:
Sucampo AGAddress:
Baarerstrasse 22, 6300, Zug, CH
Name:
NORTH CAROLINA STATE UNIVERSITYAddress:
4700 Hillsborough Street, 27606, Raleigh, NC, US
Inventor
Name:
Ueno, RyujiAddress:
Easton, MD Maryland, US
Name:
Kuno, SachikoAddress:
Easton, MD Maryland, US
Name:
Blikslager, Anthony T.Address:
Apex, NC North Carolina, US
Name:
Moeser, Adam J.Address:
Raleigh, NC North Carolina, US
Priority
Number:
663200 PDate:
21.3.2005Country:
US
Number:
679920 PDate:
11.5.2005Country:
US
Number:
721976 PDate:
30.9.2005Country:
US
Classification
Categories:
A61K 31/4152